Cargando…
Has The Time Arrived to Refine The Indications of Immunosuppressive Therapy and Prognosis in IgA Nephropathy?
Immunoglobulin A nephropathy (IgAN) is the most frequent glomerular disease worldwide and a leading cause of end-stage renal disease. Particularly challenging to the clinician is the early identification of patients at high risk of progression, an estimation of the decline in renal function, and the...
Autores principales: | Obrișcă, Bogdan, Sinescu, Ioanel, Ismail, Gener, Mircescu, Gabriel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6833025/ https://www.ncbi.nlm.nih.gov/pubmed/31581654 http://dx.doi.org/10.3390/jcm8101584 |
Ejemplares similares
-
Budesonide versus systemic corticosteroids in IgA Nephropathy: A retrospective, propensity-matched comparison
por: Ismail, Gener, et al.
Publicado: (2020) -
“Associated” or “Secondary” IgA nephropathy? An outcome analysis
por: Obrișcă, Bogdan, et al.
Publicado: (2019) -
Kidney Involvement in Hypocomplementemic Urticarial Vasculitis Syndrome—A Case-Based Review
por: Ion, Oana, et al.
Publicado: (2020) -
Antiphospholipase A2 Receptor Autoantibodies: A Step Forward in the Management of Primary Membranous Nephropathy
por: Obrisca, Bogdan, et al.
Publicado: (2015) -
Clinical Phenotypes and Predictors of Remission in Primary Membranous Nephropathy
por: Jurubiță, Roxana, et al.
Publicado: (2021)